Hui Zhao

Exosomes From Adipose-Derived Stem Cells Attenuate Adipose Inflammation and Obesity Through Polarizing M2 Macrophages and Beiging in White Adipose Tissue

Hui Zhao, Qianwen Shang, Zhenzhen Pan et al. · Diabetes · 2017 · 664 citations

Life Sciences, Cell Biology, Molecular Biology +17

Sintilimab Plus Platinum and Gemcitabine as First-Line Treatment for Advanced or Metastatic Squamous NSCLC: Results From a Randomized, Double-Blind, Phase 3 Trial (ORIENT-12)

Caicun Zhou, Caicun Zhou, Lin Wu et al. · Journal of Thoracic Oncology · 2021 · 317 citations · Full text

Medicine, Oncology, Pharmacology +8

Furmonertinib (AST2818) versus gefitinib as first-line therapy for Chinese patients with locally advanced or metastatic EGFR mutation-positive non-small-cell lung cancer (FURLONG): a multicentre, double-blind, randomised phase 3 study

Yuankai Shi, Gongyan Chen, Xiang Wang et al. · The Lancet Respiratory Medicine · 2022 · 230 citations

Medicine, Oncology, Pharmacology +13

Toripalimab Plus Chemotherapy for Patients With Treatment-Naive Advanced Non–Small-Cell Lung Cancer: A Multicenter Randomized Phase III Trial (CHOICE-01)

Zhijie Wang, Lin Wu, Baolan Li et al. · Journal of Clinical Oncology · 2022 · 172 citations · Full text

Medicine, Oncology, Pharmacology +17

M2 macrophages promote NSCLC metastasis by upregulating CRYAB

Zhe Guo, Jing Song, Junxia Hao et al. · Cell Death and Disease · 2019 · 150 citations · Full text

Medicine, Cancer Biology, Oncology +17